Skip Navigation
 
 
 
 xxx
 
Print This Page
Share this page: More
 

Publications

Peer Reviewed

Cerutti JM, Latini FR, Nakabashi C, Delcelo R, Andrade VP, Amadei MJ, Rui M B Maciel RM, Hojaij FC, Hollis D, Shoemaker J, Riggins GJ. Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers. Clin Cancer Res. 2006 Jun 1;12:3311-8.

Boon K, Eberhart C and Riggins GJ, Genomic amplification of Orthodenticle Homolog 2 (OTX2) in Medulloblastomas. Cancer Research. 2005; 65(3): 703-707.

Rand V, Huang J, Stockwell T, Ferriera S, Buzko O, Levy S, Busam D, Li K, Edwards JB, Eberhart C, Murphy KM, Tsiamouri A, Beeson K, Simpson AJ, Venter JC, Riggins GJ, and Strausberg RL. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci U S A. 2005; 102:14344-14349.

Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, and Velculescu VE. High Frequency of Mutations of the PIK3CA Gene in Human Cancers. Science. 2004; 304 (5670):554.

Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, and Riggins GJ. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest. 2004; 113:1234-1242.

Boon K, Edwards JB, Eberhart CG, and Riggins GJ. Identification of cell surface markers and astrocytomas associated genes. BMC Cancer. 2004; 4:39.

Lu J, Lal A, Merriman B, Nelson S, and Riggins GJ. A comparison of gene expression profiles produced by SAGE, long SAGE, and oligonucleotide chips. Genomics. 2004; 84: 631-636.

Siu I-M, Lal A, Blankenship JR, Aldosari N, and Riggins GJ: c-Myc promoter activation in medulloblastoma. Cancer Res. 2003; 63:4773-6.

Boon K, Edwards JB, Siu I-M, Olschner D, Eberhart CG, Marra MA, Strausberg RL, and Riggins GJ: Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes. Oncogene. 2003; 22: 7687-94.

Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, Sampson JH, and Riggins GJ: Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Research. 2002; 62:3335-3339

Boon K, Os?rio EC, Greenhut SF, Schaefer CF, Shoemaker J, Polyak K, Morin PJ, Buetow KH, Strausberg RL, De Souza SJ, and Riggins GJ: An anatomy of normal and malignant gene expression. Proceedings of the National Academy of Science. 2002; 99: 11287-11292

Lal A, Peters H, St. Croix B, Haroon ZA, Dewhirst MW, Kaanders JHAM, van der Kogel AJ, and Riggins GJ: Transcriptional response to hypoxia in human tumors. Journal of the National Cancer Institute. 2001; 93:1337-1343.

Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE, Marrra MA, Prange C, Morin PJ, Polyak K, Papadopoulos N, Vogelstein B, Kinzler KW, Strausberg RL, and Riggins GJ: A public database for gene expression in human cancers. Cancer Research. 1999; 59:5403-5407.

 
 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.